Point-Of-Care Genetic Testing Market Witness a Spike in Growth Pace Recent Improvements in Pricing Models: FMI

Point-of-Care testing is defined as the clinical testing performed at or near the site where clinical care is being given to the patient. It can be performed by patients itself or any personnel. Consecutively, analyzing the DNA and finding out the best treatment option based on the genetic makeup of the patient constitute Point-of-Care genetic testing.

This is a fast and quick technique based on personal genomics so to allow the efficient functioning of the drug. The idea behind this point-of-care genetic testing approach is to reduce the diagnosis time, inconvenience faced by patients and to follow personalized medicine approach for specific patient.

Generally, all the diseases are combination of various genetic factors, and current genetic testing techniques require a lot of time in analyzing the problem. As a result, the use of Point-of Care genetic testing systems is prevalent in quickly diagnosing and guiding the doctors to head in a right direction.

Point-of-Care Genetic testing involves amplification of genetic material and then real-time analysis to detect the genetic variations among people. The first point-of-care version of a real-time nucleic acid detection system is the Cepheid’s Xpert system, going to be launched this year.

It combines fully integrated sample preparation for amplification and detection process. This system is designed to purify, concentrate, detect, and recognize targeted nucleic acid sequences delivering diagnosis using unprocessed samples approximately within 30 minutes.

Point-of-Care Genetic Testing Market: Drivers & Restraints

The point-of-care genetic testing technology possesses convenient and immediate action for a therapeutic condition. The growth is likely to continue with the aim of providing less costly and closer to patients care. The use of genetics has become prominent nowadays in almost every pediatric condition, and this technology overcomes the limitations and challenges of current molecular testing techniques.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-3138 

Pressure on healthcare budgets and the trend to patient-centered care might be perceived as problems confined to the developed world. Moreover, the increase in population and westernization in the developing countries like China and India links it with the increase in the healthcare problems.

Due to poverty and lack of sources, Point-of-Care genetic testing technology has a major scope in these countries by providing diagnostics available at low prices and at patient’s bedside.

There are some technological limitations like failure to detect abnormal results, standardization, technological expertise, algorithmic & software complications, higher cost of maintenance & repair, poor tests result in case of contaminated samples, and sample specificity in the use of point-of-care genetic testing systems.

In addition, the high cost of Point-of-Care genetic test and limited reimbursement support is hindering the growth of point-of-care genetic testing market.